Atlas Trials

Metabolic Biomarkers Predicting Response to Neoadjuvant Immunotherapy in Non-Small Cell Lung Cancer

Clinical trial NCT07084610 · RECRUITING

Trial details

NCT number
NCT07084610
Sponsor
Hospital das Clínicas de Ribeirão Preto
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Non-Small Cell Lung Cancer
Start date
2025-02-25
Primary completion
2027-07-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.